Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2025-12-25 @ 12:24 AM
NCT ID:
NCT05022758
Eligibility Criteria:
Inclusion Criteria:
* Be ≥20 years of age (legal age in Korea) at the time of anticoagulation initiation
* Have a diagnosis of NVAF (in the 24-months prior to index date)
* Have no record of OAC use (in the 24-months prior to index date)
* Newly initiated on rivaroxaban or warfarin (index date)
Exclusion Criteria:
* Who have end-stage renal disease or are on dialysis (in the 12-months prior to index date)
* With evidence of valvular heart disease (in the 12-months prior to index date)
* With pulmonary embolism or deep vein thrombosis (within 6 months before index date)
* Who received joint replacement (within 6 months before diagnosis)
* Patients who had previous OAC prescription between 2013 and 2014
* With rivaroxaban doses other than 15 or 20 mg once daily
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT05022758
Study Brief:
Protocol Section:
NCT05022758